Skip to content
10-Q

Quarterly Report

SYNERGY PHARMACEUTICALS, INC.

0001347613-18-000032

← back to feed
Filed
Nov 9, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 8, 2018 248.04M sh
Capex Q3 2018 · Sep 30, 2018 $193K
Capex Q3 2018 · Sep 30, 2017 $48K
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$89.1M
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$89.08M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$180.05M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $45.65M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $136.99M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $117.79M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $82.39M
Stockholders Equity Q3 2018 · Sep 30, 2018 −$96.24M
Stockholders Equity Q3 2018 · Dec 31, 2017 −$5.52M
Current Liabilities Q3 2018 · Sep 30, 2018 $157.93M
Current Liabilities Q3 2018 · Dec 31, 2017 $38.15M
Total Liabilities Q3 2018 · Sep 30, 2018 $179.28M
Total Liabilities Q3 2018 · Dec 31, 2017 $172.12M
Current Assets Q3 2018 · Sep 30, 2018 $81.66M
Current Assets Q3 2018 · Dec 31, 2017 $165.16M
Total Assets Q3 2018 · Sep 30, 2018 $83.04M
Total Assets Q3 2018 · Dec 31, 2017 $166.61M
Sga Expense Q3 2018 · Sep 30, 2018 $33.89M
Sga Expense Q3 2018 · Sep 30, 2018 $108.65M
Sga Expense restated Q3 2018 · Sep 30, 2017 $45.11M
Sga Expense restated Q3 2018 · Sep 30, 2017 $140.08M
Operating Income Q3 2018 · Sep 30, 2018 −$29.61M
Operating Income Q3 2018 · Sep 30, 2018 −$97.35M
Operating Income Q3 2018 · Sep 30, 2017 −$47.7M
Operating Income Q3 2018 · Sep 30, 2017 −$184.01M
Gross Profit Q3 2018 · Sep 30, 2018 $7.18M
Gross Profit Q3 2018 · Sep 30, 2018 $20.43M
Gross Profit restated Q3 2018 · Sep 30, 2017 $3.29M
Gross Profit restated Q3 2018 · Sep 30, 2017 $2.42M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $3.92M
Cost Of Revenue Q3 2018 · Sep 30, 2018 $11.51M
Cost Of Revenue restated Q3 2018 · Sep 30, 2017 $1.72M
Cost Of Revenue restated Q3 2018 · Sep 30, 2017 $5M
Revenue Q3 2018 · Sep 30, 2018 $11.11M
Revenue Q3 2018 · Sep 30, 2018 $31.95M
Revenue Q3 2018 · Sep 30, 2017 $5.01M
Revenue Q3 2018 · Sep 30, 2017 $7.42M